Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient

James M. Gray, Rebecca K. Ameduri

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


HUS is a well-known entity primarily associated with bacterial infection and is characterized by a classic triad of anemia, thrombocytopenia, and kidney injury. Its atypical form has been associated with calcineurin inhibitors and has been extensively discussed in renal transplantation. We present a case of tacrolimus-associated HUS in a pediatric heart transplant recipient, which we believe to be previously unreported in the literature.

Original languageEnglish (US)
Pages (from-to)866-867
Number of pages2
JournalPediatric transplantation
Issue number6
StatePublished - Sep 1 2016

Bibliographical note

Publisher Copyright:
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd


  • calcineurin inhibitors
  • heart transplantation
  • hemolytic uremic syndrome
  • pediatrics


Dive into the research topics of 'Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient'. Together they form a unique fingerprint.

Cite this